FDA acknowledges the potential opportunities of cannabis-derived CBD Products

In recent years the development of therapies and other consumer products derived from cannabidiol (CBD) has increased exponentially. Public interest in CBD based health products has boomed more than any other health products in the market. Even the Federal Food, Drug and Cosmetic Administration FDA has recently recognized the various opportunities that cannabis-derived compounds may offer and acknowledges the interest in these possibilities.

Nevertheless it is vital to be extremely careful and to select the right companies that produce those CBD products. The FDA warns of companies that market CBD based products with unsubstantiated claims in ways that violate the FD&C act (Federal Food, Drug and Cosmetic Act). Some of these products could potentially endanger the health and safety of consumers which is why it is so important to be careful when choosing the right products and producers.

Information is key to select the appropriate cannabis-derived products; the FDA offers a wide selection of resources to address CBD based products in order to ensure that customers and stakeholders have the access to the right resources. Those resources include consumer information with several articles explaining all you should know about using cannabis and of course CBD, FDA Communications, Regulatory Resources & Questions and Answers.